Diary - News
All news ENYO Pharma strengthens its arsenal of hepatitis B potential therapies
This nuclear receptor, also known as a bile acid receptor, acts via several metabolic pathways and in particular by controlling the fate of bile acids in the liver and intestine. It also influences the insulin sensitivity of these tissues where it is highly expressed.